NCT00374686View on ClinicalTrials.gov

Study of Prophylactic Vs Preemptive Valganciclovir

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

September 30, 2005

Conditions
Cytomegalovirus Infection
Interventions
DRUG

Valganciclovir

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00374686 - Study of Prophylactic Vs Preemptive Valganciclovir | Biotech Hunter | Biotech Hunter